Chase City Health And Rehab Center | |
5539 Highway Forty Seven, Chase City, Virginia 23924 | |
(434) 372-8885 | |
Name | Chase City Health And Rehab Center |
---|---|
Location | 5539 Highway Forty Seven, Chase City, Virginia |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 120 |
Occupancy Rate | 83.92% |
Medicare ID (CCN) | 495380 |
Legal Business Name | Chase City Health Care Llc |
Ownership Type | For Profit - Corporation |
NPI Number | 1285603142 |
Organization Name | CHASE CITY HEALTH CARE LLC |
Doing Business As | CHASE CITY HEALTH & REHAB CENTER |
Address | 5539 Highway 47, Chase City, VA 23924 |
Phone Number | 434-372-8885 |
News Archive
The Zilver PTX Drug-Eluting Stent, the first device of its kind developed to treat peripheral artery disease (PAD) in the superficial femoral artery (SFA), has received a unanimous recommendation from the Food and Drug Administration's (FDA) Circulatory System Devices Panel of the Medical Devices Advisory Committee, Cook Medical announced today.
Adding taselisib to letrozole before surgery significantly improved outcomes for patients with early breast cancer that was both estrogen receptor positive and HER2-negative (ER+/HER2-) according to results of the LORELEI trial, presented at the ESMO 2017 Congress in Madrid.
If you're among the 18 million Americans who've been diagnosed with diabetes, you may know that foot care is extremely important. Nervous system impairment or neuropathy is a major complication of diabetes that can cause you to lose feeling in your feet. This means you may not know right away if you have hurt yourself, which could lead to infection.
Wolters Kluwer Pharma Solutions, Inc., a leading provider of market data and competitive intelligence to the pharmaceutical and biotech industries, today introduced a powerful, new version of its popular Adis R&D Insight global pipeline database.
› Verified 9 days ago
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
The Zilver PTX Drug-Eluting Stent, the first device of its kind developed to treat peripheral artery disease (PAD) in the superficial femoral artery (SFA), has received a unanimous recommendation from the Food and Drug Administration's (FDA) Circulatory System Devices Panel of the Medical Devices Advisory Committee, Cook Medical announced today.
Adding taselisib to letrozole before surgery significantly improved outcomes for patients with early breast cancer that was both estrogen receptor positive and HER2-negative (ER+/HER2-) according to results of the LORELEI trial, presented at the ESMO 2017 Congress in Madrid.
If you're among the 18 million Americans who've been diagnosed with diabetes, you may know that foot care is extremely important. Nervous system impairment or neuropathy is a major complication of diabetes that can cause you to lose feeling in your feet. This means you may not know right away if you have hurt yourself, which could lead to infection.
Wolters Kluwer Pharma Solutions, Inc., a leading provider of market data and competitive intelligence to the pharmaceutical and biotech industries, today introduced a powerful, new version of its popular Adis R&D Insight global pipeline database.
› Verified 9 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 1 |
Total Amount of Fines in Dollars | $11616 |
Number of Payment Denials | 0 |
Total Number of Penalties | 1 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 18.1 | 14.46 |
Percentage of long-stay residents who lose too much weight | 13.77 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 58.14 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 0.58 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 2.68 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 4.19 | 5.05 |
Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 4.26 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 94.95 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 16.77 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 63.48 | 83.88 |
Percentage of short-stay residents who newly received an antipsychotic medication | 3.21 | 1.79 |
Percentage of long-stay residents whose ability to move independently worsened | 43.18 | 17.09 |
Percentage of long-stay residents who received an antianxiety or hypnotic medication | 14.17 | 19.7 |
Percentage of high risk long-stay residents with pressure ulcers | 5.33 | 7.32 |
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 97.66 | 95.98 |
Percentage of short-stay residents who made improvements in function | 85.95 | 67.99 |
Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 72.07 | 82.93 |
News Archive
The Zilver PTX Drug-Eluting Stent, the first device of its kind developed to treat peripheral artery disease (PAD) in the superficial femoral artery (SFA), has received a unanimous recommendation from the Food and Drug Administration's (FDA) Circulatory System Devices Panel of the Medical Devices Advisory Committee, Cook Medical announced today.
Adding taselisib to letrozole before surgery significantly improved outcomes for patients with early breast cancer that was both estrogen receptor positive and HER2-negative (ER+/HER2-) according to results of the LORELEI trial, presented at the ESMO 2017 Congress in Madrid.
If you're among the 18 million Americans who've been diagnosed with diabetes, you may know that foot care is extremely important. Nervous system impairment or neuropathy is a major complication of diabetes that can cause you to lose feeling in your feet. This means you may not know right away if you have hurt yourself, which could lead to infection.
Wolters Kluwer Pharma Solutions, Inc., a leading provider of market data and competitive intelligence to the pharmaceutical and biotech industries, today introduced a powerful, new version of its popular Adis R&D Insight global pipeline database.
› Verified 9 days ago
Chase City Health And Rehab Center Location: 5539 Highway Forty Seven, Chase City, Virginia 23924 Phone: (434) 372-8885 |